到 2028 年北美护理点分子诊断市场预测 - 按产品和服务（检测和试剂盒、仪器、服务和软件）、技术（PCR、等温核酸扩增技术 (INAAT)）划分的 COVID-19 影响和区域分析和其他技术）、应用（传染病、肿瘤学、血液学、产前检测、内分泌学和其他应用）、最终用户（医院和诊所、诊断实验室、研究和学术机构等）

市场介绍

即时分子诊断包括便携式设备以及检测和分析;用于检测和诊断人类样本中疾病的试剂盒，例如咽拭子、血液、血清和粪便。分子诊断正在从集中实验室转向分散的护理点分子测试。由于其简单、方便、周转时间短以及改善患者治疗效果的潜力，POCT 正在迅速获得关注。

此外，对消耗特定病毒检测方法的需求不断增长及时感染控制的时间减少预计将在预测期内促进市场增长。

美国是北美所有国家中 COVID-19 病例数量最多的国家。这对该地区的各个行业以及供应链和分销链产生了负面影响。在大流行期间，生命科学公司将重点转向开发治疗危及生命的疾病的新药。此外，对快速检测设备的需求也有所增加，这在北美即时分子诊断市场的增长中发挥着突出作用。此外，COVID-19 的持续传播正在增加对即时分子诊断试剂盒的需求。这些套件的采用正在促进新产品的开发和发布。 2021 年 3 月，Eurofins 旗下的 Clinical Enterprise, Inc. 获得了美国食品和药物管理局 (FDA) 的紧急使用授权 (EUA)，用于其 EmpowerDX COVID-19 家庭采集套件的直接面向消费者 (DTC) 版本。同样，2020 年 7 月，Eurofins USA 的临床诊断公司宣布推出聚合 PCR 检测来检测 SARS-CoV-2，这将大大降低客户每次 PCR 检测的成本。

市场概况和动态

北美即时分子诊断市场预计将达到到 2028 年，该市场的价值将从 2021 年的 8.609 亿美元增至 21.101 亿美元。预计从 2021 年到 2028 年，该市场将以 13.7% 的复合年增长率增长。持续的COVID-19大流行也为检测新型冠状病毒的POC分子诊断试剂盒制造商创造了机会。例如，全球医疗保健和医疗设备制造商雅培（ABBOTT）推出了ID NOW。它是一种分子即时护理仪器，可在五分钟内检测出新的冠状病毒感染。 ID NOW 是一种基于仪器的快速等温技术，用于定性检测传染病。其专有的等温核酸扩增产品和技术服务可在几秒钟内生成分子数据，使医生能够在患者就诊期间做出基于证据的治疗决策。 ID NOW 尚未获得美国食品和药物管理局 (FDA) 的认证或批准。它已获得 FDA 批准，可根据紧急使用授权 (EUA) 在授权实验室和患者护理机构中使用。此类创新和产品开发预计将为预测期内北美即时分子诊断市场的增长提供利润丰厚的机会。

主要细分市场

在产品和服务方面服务方面，检测和试剂盒细分市场在 2020 年北美床边护理分子诊断市场中占据最大份额。在技术方面，PCR 细分市场在北美床边护理分子诊断市场中占据最大份额2020年诊断市场。就应用而言，传染病细分市场在2020年北美即时分子诊断市场中占据最大份额。就最终用户而言，诊断实验室细分市场占据最大份额2020 年北美即时分子诊断市场。

主要来源和上市公司

准备本北美护理点分子诊断市场报告时提到的一些主要一手和二手来源是公司网站、年度报告、财务报告、国家政府文件、统计数据库等。报告中列出的主要公司包括 BioMérieux SA、F. Hoffmann-La Roche Ltd.、Danaher Corporation、Enzo Biochem, Inc.、Abbott、binx health, Inc.、Meridian BioScience, Inc.、Biocartis、Quidel Corporation 和Bio-Rad Laboratories, Inc.

购买报告的理由

了解北美即时分子诊断市场格局并确定可能保证丰厚回报的细分市场
了解不断变化的市场格局并在竞争中保持领先
有效规划北方地区的并购和合作交易通过识别最有希望销售的细分市场，美国护理点分子诊断市场
通过对各个细分市场的市场表现进行敏锐和全面的分析，做出明智的业务决策
获取 2021 年至 2028 年北美护理点分子诊断市场基于各个细分市场的市场收入预测

北美护理点分子诊断市场细分

按产品和amp ;服务

检测和试剂盒
仪器
服务和软件

按技术

PCR
等温核酸扩增技术（INAAT）
其他技术

作者应用

作者最终用户

医院和诊所
诊断实验室
研究及学术机构
其他

按国家/地区

北美
- 美国
- 加拿大
- 墨西哥

提及的公司

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 North America Point-of-Care Molecular Diagnostics Market – By Product & Services

1.3.2 North America Point-of-Care Molecular Diagnostics Market – By Technology

1.3.3 North America Point-of-Care Molecular Diagnostics Market – By Application

1.3.4 North America Point-of-Care Molecular Diagnostics Market – By End User

1.3.5 North America Point-of-Care Molecular Diagnostics Market– By Geography

2. North America Point-of-Care Molecular Diagnostics Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Point-of-Care Molecular Diagnostics Market– Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 North America – PEST Analysis

4.3 Experts Opinion

5. Point-of-Care Molecular Diagnostics Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Growing Demand for Specific Viral Detection Methods that Consume Less Time for Timely Infection Control

5.1.2 Rising Incidences of Infectious Diseases

5.2 Market Restraints

5.2.1 Pricing Pressures owing to Reimbursement Cuts

5.3 Market Opportunities

5.3.1 Rising R&D and Innovation in Point-of-Care Molecular Diagnostics

5.4 Future Trends

5.4.1 Rising Implementation of Molecular Point-of-Care Diagnostic Devices and Kits across Residential Setting

5.5 Impact Analysis

6. Point-of-Care Molecular Diagnostics Market– North America Analysis

6.1 North America Point-of-Care Molecular Diagnostics Market Revenue Forecast and Analysis

7. Point-of-Care Molecular Diagnostics Market Analysis and Forecast to 2028 – By Product & services

7.1 Overview

7.2 Point-of-Care Molecular Diagnostics Market, by Product & services 2020 & 2028 (%)

7.3 Assays and Kits

7.3.1 Overview

7.3.2 Assays and Kits: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Instruments

7.4.1 Overview

7.4.2 Instruments: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.5 Services and Software

7.5.1 Overview

7.5.2 Services and Software: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8. Point-of-Care Molecular Diagnostics Market Analysis and Forecast to 2028 – By Technology

8.1 Overview

8.2 Point-of-Care Molecular Diagnostics Market, by Technology 2020 & 2028 (%)

8.3 PCR

8.3.1 Overview

8.3.2 PCR: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Isothermal Nucleic Acid Amplification Technology (INAAT)

8.4.1 Overview

8.4.2 Isothermal Nucleic Acid Amplification Technology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Others

8.5.1 Overview

8.5.2 Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9. Point-of-Care Molecular Diagnostics Market Analysis – By Application

9.1 Overview

9.2 Point-of-Care Molecular Diagnostics Market, by Application 2020 & 2028 (%)

9.3 Infectious Disease

9.3.1 Overview

9.3.2 Infectious Disease: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.4 Oncology

9.4.1 Overview

9.4.2 Oncology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.5 Hematology

9.5.1 Overview

9.5.2 Hematology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.6 Prenatal Testing

9.6.1 Overview

9.6.2 Prenatal Testing: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.7 Endocrinology

9.7.1 Overview

9.7.2 Endocrinology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.8 Others

9.8.1 Overview

9.8.2 Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10. Point-of-Care Molecular Diagnostics Market Analysis and Forecast to 2028 – By End User

10.1 Overview

10.2 Point-of-Care Molecular Diagnostics Market, by End User 2020 & 2028 (%)

10.3 Hospitals and Clinics

10.3.1 Overview

10.3.2 Hospitals and Clinics: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.4 Diagnostic Laboratories

10.4.1 Overview

10.4.2 Diagnostic Laboratories: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.5 Research and Academic Institutes

10.5.1 Overview

10.5.2 Research and Academic Institutes: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.6 Others

10.6.1 Overview

10.6.2 Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

11. North America Point-of-Care Molecular Diagnostics Market – Geographic Analysis

11.1 North America: Point-of-Care Molecular Diagnostics Market

11.1.1 Overview

11.1.2 North America: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (USD Million)

11.1.3 North America Point-of-Care Molecular Diagnostics Market, by Product & services – Revenue and Forecast to 2028 (USD Million)

11.1.4 North America Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

11.1.5 North America Point-of-Care Molecular Diagnostics Market, by Application– Revenue and Forecast to 2028 (USD Million)

11.1.6 North America Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

11.1.7 North America: Point-of-Care Molecular Diagnostics Market, by Country, 2021 & 2028 (%)

11.1.7.1 US: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

11.1.7.1.1 US: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

11.1.7.1.2 US Point-of-Care Molecular Diagnostics Market, by Product & services – Revenue and Forecast to 2028 (USD Million)

11.1.7.1.3 US Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

11.1.7.1.4 US Point-of-Care Molecular Diagnostics Market, by Application– Revenue and Forecast to 2028 (USD Million)

11.1.7.1.5 US Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

11.1.7.2 Canada: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

11.1.7.2.1 Canada: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

11.1.7.2.2 Canada Point-of-Care Molecular Diagnostics Market, by Product & services – Revenue and Forecast to 2028 (USD Million)

11.1.7.2.3 Canada Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

11.1.7.2.4 Canada Point-of-Care Molecular Diagnostics Market, by Application– Revenue and Forecast to 2028 (USD Million)

11.1.7.2.5 Canada Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

11.1.7.3 Mexico: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

11.1.7.3.1 Mexico: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

11.1.7.3.2 Mexico Point-of-Care Molecular Diagnostics Market, by Product & services – Revenue and Forecast to 2028 (USD Million)

11.1.7.3.3 Mexico Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

11.1.7.3.4 Mexico Point-of-Care Molecular Diagnostics Market, by Application– Revenue and Forecast to 2028 (USD Million)

11.1.7.3.5 Mexico Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

12. Impact Of COVID-19 Pandemic on Point-of-Care Molecular Diagnostics Market

12.1 North America: Impact Assessment of COVID-19 Pandemic

13. Point-of-Care Molecular Diagnostics Market– Industry Landscape

13.1 Overview

13.2 Growth Strategies in the Point-of-Care Molecular Diagnostics Market, 2018-2021

13.3 Organic Growth Strategies

13.3.1 Overview

13.4 Inorganic Growth Strategies

13.4.1 Overview

14. Company Profiles

14.1 F. Hoffmann-La Roche Ltd.

14.1.1 Key Facts

14.1.2 Business Description

14.1.3 Products and Services

14.1.4 Financial Overview

14.1.5 SWOT Analysis

14.1.6 Key Developments

14.2 bioMérieux SA

14.2.1 Key Facts

14.2.2 Business Description

14.2.3 Products and Services

14.2.4 Financial Overview

14.2.5 SWOT Analysis

14.2.6 Key Developments

14.3 Abbott

14.3.1 Key Facts

14.3.2 Business Description

14.3.3 Products and Services

14.3.4 Financial Overview

14.3.5 SWOT Analysis

14.3.6 Key Developments

14.4 MERIDIAN BIOSCIENCE, INC.

14.4.1 Key Facts

14.4.2 Business Description

14.4.3 Products and Services

14.4.4 Financial Overview

14.4.5 SWOT Analysis

14.4.6 Key Developments

14.5 Enzo Biochem Inc.

14.5.1 Key Facts

14.5.2 Business Description

14.5.3 Products and Services

14.5.4 Financial Overview

14.5.5 SWOT Analysis

14.5.6 Key Developments

14.6 Biocartis

14.6.1 Key Facts

14.6.2 Business Description

14.6.3 Products and Services

14.6.4 Financial Overview

14.6.5 SWOT Analysis

14.6.6 Key Developments

14.7 Quidel Corporation

14.7.1 Key Facts

14.7.2 Business Description

14.7.3 Products and Services

14.7.4 Financial Overview

14.7.5 SWOT Analysis

14.7.6 Key Developments

14.8 Danaher

14.8.1 Key Facts

14.8.2 Business Description

14.8.3 Products and Services

14.8.4 Financial Overview

14.8.5 SWOT Analysis

14.8.6 Key Developments

14.9 BIO-RAD LABORATORIES INC.

14.9.1 Key Facts

14.9.2 Business Description

14.9.3 Products and Services

14.9.4 Financial Overview

14.9.5 SWOT Analysis

14.9.6 Key Developments

14.10 binx health, inc.

14.10.1 Key Facts

14.10.2 Business Description

14.10.3 Products and Services

14.10.4 Financial Overview

14.10.5 SWOT Analysis

14.10.6 Key Developments

15. Appendix

15.1 About The Insight Partners

15.2 Glossary of Terms

LIST OF TABLES

Table 1. North America Point-of-Care Molecular Diagnostics Market, by Product & services – Revenue and Forecast to 2028 (USD Million)

Table 2. North America Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 3. North America Point-of-Care Molecular Diagnostics Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 4. North America Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 5. US Point-of-Care Molecular Diagnostics Market, by Product & services – Revenue and Forecast to 2028 (USD Million)

Table 6. US Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 7. US Point-of-Care Molecular Diagnostics Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 8. US Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 9. Canada Point-of-Care Molecular Diagnostics Market, by Product & services -Revenue and Forecast to 2028 (USD Million)

Table 10. Canada Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 11. Canada Point-of-Care Molecular Diagnostics Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 12. Canada Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 13. Mexico Point-of-Care Molecular Diagnostics Market, by Product & services -Revenue and Forecast to 2028 (USD Million)

Table 14. Mexico Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 15. Mexico Point-of-Care Molecular Diagnostics Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 16. Mexico Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 17. Recent Organic Developments the Point-of-Care Molecular Diagnostics Market

Table 18. Recent Inorganic Developments in the Point-of-Care Molecular Diagnostics Market

Table 19. Glossary of Terms, Point-of-Care Molecular Diagnostics Market

LIST OF FIGURES

Figure 1. Point-of-Care Molecular Diagnostics Market Segmentation

Figure 2. North America Point-of-Care Molecular Diagnostics Market Overview

Figure 3. Assays and Kits Segment Held the Largest Share by Product & services in North America Point-of-Care Molecular Diagnostics Market

Figure 4. US to Show Significant Growth During Forecast Period

Figure 5. North America Point-of-Care Molecular Diagnostics Market, Industry Landscape

Figure 6. North America PEST Analysis

Figure 7. North America Point-of-Care Molecular Diagnostics Market– Revenue Forecast and Analysis – 2020- 2028

Figure 8. Point-of-Care Molecular Diagnostics Market, by Product & services 2020 & 2028 (%)

Figure 9. Assays and Kits: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 10. Instruments: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11. Services and Software: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12. Point-of-Care Molecular Diagnostics Market, by Technology 2020 & 2028 (%)

Figure 13. PCR: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14. Isothermal Nucleic Acid Amplification Technology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15. Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16. Point-of-Care Molecular Diagnostics Market, by Application 2020 & 2028 (%)

Figure 17. Infectious Disease: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18. Oncology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19. Hematology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20. Prenatal Testing: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21. Endocrinology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22. Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23. Point-of-Care Molecular Diagnostics Market, by End User 2020 & 2028 (%)

Figure 24. Hospitals and Clinics: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25. Diagnostic Laboratories: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26. Research and Academic Institutes: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27. Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28. North America: Point-of-Care Molecular Diagnostics Market, by Key Country – Revenue (2021) (USD Million)

Figure 29. North America Point-of-Care Molecular Diagnostics Market Revenue and Forecast to 2028 (USD Million)

Figure 30. North America: Point-of-Care Molecular Diagnostics Market, by Country, 2021 & 2028 (%)

Figure 31. US: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 32. Canada: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 33. Mexico: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 34. Impact of COVID-19 Pandemic on Point-of-Care Molecular Diagnostic Market in North America

Figure 35. Growth Strategies in the Point-of-Care Molecular Diagnostics Market, 2018-2021

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America Point-of-Care molecular diagnostics market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the North America Point-of-Care molecular diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
North America Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software a..	May 2022
North America Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Ele..	May 2022
North America Cabinet LED Lighting Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (In-cabinet Lighting and Under-Cabinet Ligh..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000